Last August, Stephen A. Chagares, a breast surgeon, made an announcement that startled some of his colleagues at New Jersey’s Monmouth Medical Center. At internal meetings and in a press release, Chagares declared that he would perform a robotic mastectomy—a new and relatively untested minimally invasive surgical procedure. According to the press release, his first patient, Yvonne Zucco, 56, was being treated for stage IIa breast cancer.
I enjoy your publication and read it cover to cover most weeks. But I must point out a glaring error in your recent edition of March 22. The illustrations accompanying the article about the Texas cancer researchers show saguaro cacti. Saguaro cacti only grow in the Sonoran desert of southern Arizona and western Sonora, Mexico, with a few stray saguaros in California. The saguaro cactus does not grow in Texas. It is a common misconception that the saguaro grows throughout the west. The cactus is so unique to Arizona that the saguaro cactus blossom has been named the state flower of Arizona. I thought you should be made aware of this inaccuracy.
The ever-rising cost of oncology drugs is doing damage to cancer care on many levels.
Many have written and spoken about the goal of eliminating the effect of developing and delivering medical care in “silos.”
The Tomosynthesis Mammographic Imaging Screening Trial, a massive randomized trial of early detection, is asking an important question:
President Donald Trump has proposed to cut $4.7 billion from the NIH budget, with almost $900 million coming out of NCI during the fiscal year 2020.
It was a thrilling moment for me when, sitting on my living room couch, listening to the State of the Union address, I heard the president say:
Matthew Ong spoke with Charles Roberts.
Matthew Ong spoke with Adam Resnick.
